Skip to main content
logo
PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
2.250
-0.010 (-0.44%)
Aug 28, 2026, 4:10 PM AEST

PYC Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
2,2231,657755560191207
Market Cap Growth
193.14%119.41%34.90%192.66%-7.47%-58.06%
Enterprise Value
2,1031,537708536175165
Last Close Price
2.261.691.261.170.540.62

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-20.0020.0020.0020.0020.00
PS Ratio
108.1141.7732.1525.3812.1012.89
PB Ratio
15.092.394.446.916.735.14
P/TBV Ratio
15.502.404.567.338.145.92

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
102.2938.7530.1224.2911.1010.26

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.000.000.010.010.010.02
Net Debt / Equity Ratio
-0.64-0.64-0.89-0.81-0.54-0.70
Net Debt / EBITDA Ratio
10.5110.512.881.730.672.06
Net Debt / FCF Ratio
9.929.922.891.690.611.27
Asset Turnover
0.090.090.170.340.380.31
Quick Ratio
33.4433.4414.389.323.798.93
Current Ratio
33.4833.4814.419.403.798.95
Return on Equity (ROE)
-10.14%-10.14%-40.64%-69.61%-68.05%-30.37%
Return on Assets (ROA)
-6.13%-6.13%-24.42%-37.83%-35.49%-17.29%
Return on Capital Employed (ROCE)
-6.30%-6.30%-31.40%-47.30%-81.50%-34.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-2.14%-2.61%-6.66%-6.74%-11.91%-6.71%
FCF Yield
-2.98%-2.72%-6.96%-6.95%-13.02%-10.72%
Buyback Yield / Dilution
-27.58%-46.52%-27.16%-22.59%-0.93%-2.89%